Recent studies have shown that CXCL12 is a potent chemokine for selective marrow neutrophil recruitment [47] into the lungs to sustain inflammation in ARDS, and blockade of CXCL12 alleviates lung injury and improves the survival rates of ARDS mice [48, 49]. Here, CXCL12 is linked to acute respiratory distress syndrome.